241 related articles for article (PubMed ID: 10088206)
1. An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure.
Klinge R; Hystad M; Kjekshus J; Karlberg BE; Djøseland O; Aakvaag A; Hall C
Scand J Clin Lab Invest; 1998 Dec; 58(8):683-91. PubMed ID: 10088206
[TBL] [Abstract][Full Text] [Related]
2. Cardiac secretion of atrial and brain natriuretic peptides in acute ischaemic heart failure in pigs: effect of angiotensin II receptor antagonism.
Klinge R; Djøseland O; Karlberg BE; Hall C
Clin Physiol; 1997 Jul; 17(4):389-400. PubMed ID: 19361150
[TBL] [Abstract][Full Text] [Related]
3. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
[TBL] [Abstract][Full Text] [Related]
4. Cardiac natriuretic peptides and continuously monitored atrial pressures during chronic rapid pacing in pigs.
Qi W; Kjekshus H; Klinge R; Kjekshus JK; Hall C
Acta Physiol Scand; 2000 Jun; 169(2):95-102. PubMed ID: 10848639
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
[TBL] [Abstract][Full Text] [Related]
6. How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines.
Missouris CG; Grouzmann E; Buckley MG; Barron J; MacGregor GA; Singer DR
Clin Sci (Lond); 1998 Jun; 94(6):591-9. PubMed ID: 9854456
[TBL] [Abstract][Full Text] [Related]
7. Contrasting cardiac regional responses of A-type and B-type natriuretic peptide to experimental chronic heart failure.
Hystad ME; Klinge R; Spurkland A; Attramadal H; Hall C
Scand J Clin Lab Invest; 2000 Jul; 60(4):299-309. PubMed ID: 10943600
[TBL] [Abstract][Full Text] [Related]
8. Neurohormones in an ovine model of compensated postinfarction left ventricular dysfunction.
Rademaker MT; Cameron VA; Charles CJ; Espiner EA; Nicholls MG; Pemberton CJ; Richards AM
Am J Physiol Heart Circ Physiol; 2000 Mar; 278(3):H731-40. PubMed ID: 10710340
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
[TBL] [Abstract][Full Text] [Related]
10. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
[TBL] [Abstract][Full Text] [Related]
11. Differential responses of plasma atrial and brain natriuretic peptides to acute alteration in atrial pressure in pigs.
Qi W; Kjekshus J; Hall C
Scand J Clin Lab Invest; 2000 Feb; 60(1):55-63. PubMed ID: 10757454
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive peptide release in relation to hemodynamic and metabolic changes during rapid ventricular pacing.
Ylitalo K; Uusimaa P; Vuolteenaho O; Ruskoaho H; Peuhkurinen K
Pacing Clin Electrophysiol; 1999 Jul; 22(7):1064-70. PubMed ID: 10456635
[TBL] [Abstract][Full Text] [Related]
13. The neuro-cardio-endocrine response to acute subarachnoid haemorrhage.
Espiner EA; Leikis R; Ferch RD; MacFarlane MR; Bonkowski JA; Frampton CM; Richards AM
Clin Endocrinol (Oxf); 2002 May; 56(5):629-35. PubMed ID: 12030914
[TBL] [Abstract][Full Text] [Related]
14. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.
Hystad ME; Geiran OR; Attramadal H; Spurkland A; Vege A ; Simonsen S; Hall C
Acta Physiol Scand; 2001 Apr; 171(4):395-403. PubMed ID: 11421854
[TBL] [Abstract][Full Text] [Related]
15. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
Loke I; Squire IB; Davies JE; Ng LL
Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
[TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure.
Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Nicholls MG; Richards AM
Clin Sci (Lond); 2004 Jun; 106(6):569-76. PubMed ID: 14723602
[TBL] [Abstract][Full Text] [Related]
17. Dual natriuretic peptide system in experimental heart failure.
Moe GW; Grima EA; Wong NL; Howard RJ; Armstrong PW
J Am Coll Cardiol; 1993 Sep; 22(3):891-8. PubMed ID: 8354829
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations.
Groenning BA; Nilsson JC; Sondergaard L; Kjaer A; Larsson HB; Hildebrandt PR
Eur J Heart Fail; 2001 Dec; 3(6):699-708. PubMed ID: 11738222
[TBL] [Abstract][Full Text] [Related]
19. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure.
Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
J Vet Med Sci; 1999 May; 61(5):523-9. PubMed ID: 10379945
[TBL] [Abstract][Full Text] [Related]
20. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
